Potentiating Antibody-Dependent Cellular Cytotoxicity in Triple-Negative Breast Cancer via the Humanized Anti-CD147 Antibody

Potentiating Antibody-Dependent Cellular Cytotoxicity in Triple-Negative Breast Cancer via the Humanized Anti-CD147 Antibody

Background: Triple-negative breast cancer (TNBC) is an aggressive subtype with high metastatic potential, poor prognosis, and the absence of estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2 (HER2). The lack of these receptors limits the standard treatments, su...

Full description

Saved in:
Bibliographic Details
Main Authors: Kanyarat Thongheang, Thanathat Pamonsupornwichit, Kanokporn Sornsuwan, On-anong Juntit, Tawan Chokepaichitkool, Weeraya Thongkum, Umpa Yasamut, Chatchai Tayapiwatana
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Antibodies
Subjects:
triple-negative breast cancer
CD147
antibody therapy
ADCC
humanized antibody
Online Access:https://www.mdpi.com/2073-4468/14/2/36
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.mdpi.com/2073-4468/14/2/36

Similar Items